We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
- Authors
Brown, Darron R; Kjaer, Susanne K; Sigurdsson, Kristján; Iversen, Ole-Erik; Hernandez-Avila, Mauricio; Wheeler, Cosette M; Perez, Gonzalo; Koutsky, Laura A; Tay, Eng Hseon; Garcia, Patricía; Ault, Kevin A; Garland, Suzanne M; Leodolter, Sepp; Olsson, Sven-Eric; Tang, Grace W K; Ferris, Daron G; Paavonen, Jorma; Steben, Marc; Bosch, F Xavier; Dillner, Joakim; Joura, Elmar A; Kurman, Robert J; Majewski, Slawomir; Muñoz, Nubia; Myers, Evan R; Villa, Luisa L; Taddeo, Frank J; Roberts, Christine; Tadesse, Amha; Bryan, Janine; Lupinacci, Lisa C; Giacoletti, Katherine E D; Sings, Heather L; James, Margaret; Hesley, Teresa M; Barr, Eliav
- Abstract
Human papillomavirus (HPV)-6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18-related cervical intraepithelial neoplasia (CIN) 1-3 or adenocarcinoma in situ (AIS). Here, its impact on CIN1-3/AIS associated with nonvaccine oncogenic HPV types was evaluated.
- Publication
The Journal of infectious diseases, 2009, Vol 199, Issue 7, p926
- ISSN
0022-1899
- Publication type
Journal Article
- DOI
10.1086/597307